Fort Pitt Capital Group, LLC Amgen Inc Transaction History

Fort Pitt Capital Group, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 16, 2021	SELL	$221.91 - $258.6 $27,073 - $31,549	-122 Closed	0 $0
Q4 2020 Feb 23, 2021	BUY	$216.38 - $257.67 $26,398 - $31,435	122 New	122 $28,000
Q2 2018 Aug 09, 2018	SELL	$166.05 - $186.51 $804,014 - $903,081	-4,842 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$169.43 - $198.0 $13.1 Million - $15.3 Million	-77,277 Reduced 94.1%	4,842 $826,000
Q4 2017 Feb 02, 2018	SELL	$168.79 - $188.59 $143,640 - $160,490	-851 Reduced 1.03%	82,119 $14.3 Million
Q3 2017 Oct 26, 2017	SELL	$167.29 - $191.0 $98,366 - $112,308	-588 Reduced 0.7%	82,970 $15.5 Million
Q2 2017 Aug 17, 2017	BUY	N/A	83,558	83,558 $14.4 Million

3,055

409M

7.19M

6.26M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Fort Pitt Capital Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Fort Pitt Capital Group, LLC with notifications on news.